Home
Mission
Rights and Ethics
Homeless Assistance
Mobile Crisis Team
Child Trauma Services
Psychiatry
- News -
Human Resources
Quality Assurance
Financials
How to Donate to MHS
Directions
Join Our Mailing List
  The mission of MHS is to help people gain control of their lives by forging solutions that resolve mental health crises and end homelessness.  Photograph from The Plain Dealer of 6 November 2007, p. A1.

Healthcare &
Psychology News -
2006
Understanding health. Designing systems of care.

Healthcare & Psychology News 2008

News

Recent Events

- More -

The protection, management, and restoration of health are among the most complex of human endeavors. Efforts to define health, and to design and conduct healthcare interventions draw on contributions from many sources, including the theoretical and applied sciences, philosophy, ethics, business management, government, and public policy. As a participant in these efforts, MHS must be a learning organization that can navigate with competence and efficiency the dynamic landscape of new scientific knowledge; changing scientific, cultural, and political values; federal, state, and local laws and administrative rules; service, certification, reporting, and compliance standards; and community priorities.

Here, we present capsule summaries of pertinent scientific, governmental, business, and other developments that may affect how we understand our mission, and the steps we take to fulfill it.




6 September 2006

Researchers calculate that bipolar and major depressive disorders cost the U.S. $51 billion each year because of sick days and performance impairments.

Cover of the September 2006 issue of the 
American Journal of Psychiatry.

Major mood disorders affecting U.S. workers cost the nation an estimated $51 billion because of lost productivity and absenteeism, according to a study funded the National Institute of Mental Health (NIMH). Published in the September 2006 issue of the American Journal of Psychiatry, the study was based on the responses of 3,378 workers from a nationally representative sample of 9,282 adults surveyed in 2001-2003. Each respondent participated in a structured diagnostic interview, and answered questions about their work performance.

More than six percent (6%) of respondents reported symptoms that met diagnostic criteria for Major Depressive Disorder. About one percent (1%) met criteria for Bipolar Disorder.

People who have major depressive disorder experience sustained periods of depressed mood or severe loss of interest in usual activities, accompanied by disturbances in sleep, appetite, and activity. Many also have suicidal ideas or conduct, and up to 15% of those with severe depression die by suicide. Untreated episodes typically last at least six months. At any given time, major depression has been found to affect more than 5% of women, and more than 2% of men.

Those who have bipolar disorder have manic episodes characterized by expansive or irritable moods, grandiosity, racing thoughts or speech, agitation, and unusual risk-taking conduct. Many of those affected by bipolar disorder also have episodes of major depression or a similar mood disturbance. These depressive episodes alternate with, or are superimposed on, manic episodes. Untreated manic episodes typically last from a few weeks to a few months, and tend to end more abruptly than depressive episodes. Bipolar disorder affects more than 1% of men and women, equally.

Selected results of the study are presented in the table below. Although major depression was about six times more prevalent than bipolar disorder, the typical worker with bipolar disorder was absent from work more than twice as many days in a year than the worker with major depression. Analysis of the study results showed that this difference was because the depressive episodes of those with bipolar disorder were more severe than the depressive episodes of those with major depression. Because there are interventions of demonstrated effectiveness for both major depression and bipolar disorder, the study suggests that early identification and assertive efforts to treat these disorders could substantially reduce the workplace costs of these relatively common disorders.

A table presenting the prevalence, duration, and costs of bipolar and major depressive disorders, from the Kessler et al. study of September 2006.

Reference
Kessler, R.C., Akiskal, H.S., Ames, M., Birnbaum, H., Greenberg, P., Hirschfeld, R.M.A., Jin, R., Merikangas, K.R., Simon, G.K., & Wang, P.S. (2006). Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. American Journal of Psychiatry, 163, pp. 1561-1568. Click here for an abstract of the study, on the website of the American Journal of Psychiatry, in a separate browser window.





15 August 2006

People with schizophrenia have variations in genes that regulate the growth of specialized nerve cells.

Proceedings of the National Academy of 
Sciences of the United States of America.

People with schizophrenia have more frequent variations in three genes that regulate the growth of myelin, according to research published in the 15 August 2006 issue of the Proceedings of the National Academy of Sciences of the USA. Myelin is the fatty covering of many nerve cells in the central nervous system, and is critical to their proper functioning. Myelin is produced by specialized nerve cells, called oligodendrocytes, that are regulated by a gene called the oligodendrocyte lineage transcription factor 2, or OLIG2, as well as other genes.

Prior research had shown that the brains of people with schizophrenia have fewer oligodendrocytes, and some researchers believe that abnormal functioning of oligodendrocytes is one of the primary causes of schizophrenia. Researchers in the current study wanted to determine if the structure of the genes that control the growth of oligodendrocytes was different in people who had schizophrenia. The researchers were from the Cardiff University School of Medicine in the United Kingdom, and the Mount Sinai School of Medicine in New York City.

Researchers examined the structure of OLIG2 and three other genes by analyzing DNA from blood samples of 673 people with schizophrenia, and 716 people without it. Results of the analyses showed that variations in OLIG2 were much more frequently found in people with schizophrenia, and that variations in OLIG2 were associated with variations in two of the three other genes they examined. The authors concluded: "Our data provide strong convergent evidence that variation in OLIG2 confers susceptibility to schizophrenia alone and as part of a network of genes implicated in oligodendrocyte function."

Damage to the myelin sheath that surrounds parts of the nerve cells in the brain and spinal cord is also implicated in multiple sclerosis (MS), a chronic and potentially debilitating disease that affects more than a million people globally. In MS, however, damage to myelin is thought to arise from a different mechanism, in which the body's own immune cells attack the myelin as though it were a foreign substance. Damage to the myelin eventually causes injury to the nerves it surrounds. That damage interferes with vision and other senses, and with muscle strength, control, and coordination. If abnormal or damaged myelin is shown to be an important cause of schizophrenia, then drugs developed for MS might have benefits for those with schizophrenia.

Reference
Georgieva, L., Moskvina, V., Peirce, T., Norton, N., Bray, N.J., Jones, L., Holmans, P., MacGregor, S., Zammit, S., Wilkinson, J., Williams, H., Nikolov, I., Williams, N., Ivanov, D., Davis, K. L., Haroutunian, V., Buxbaum, J.D., Craddock, N., Kirov, G., Owen, M.O., & O’Donovan,M.C. (2006, August 15). Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proceedings of the National Academy of Sciences, 103, 12469-12474. Abstract at http://www.pnas.org/cgi/doi/10.1073/pnas.0603029103




28 February 2006

Depression is more likely among adolescents who witness violence between their parents.

American Journal of Public Health

Adolescents between the ages of 17 and 19 years who witness domestic violence between their parents are significantly more likely to report symptoms of depression, according to a study in the Philippines. In face-to-face interviews of 2,051 young men and women, nearly half reported witnessing parental domestic violence. Among the young women, those who witnessed violent events for which a parent required medical attention reported the most severe depression during the month prior to the interview. Among the young men, those who reported events in which both parents were violent reported the most severe depression. Twenty percent of the female adolescents, and ten percent of the males reported wishing they were dead occasionally or most of the time in the month preceding the survey.

The World Health Organization reports that suicide is the third leading cause of death among adolescents worldwide. There are more than one billion children of 10-19 years of age in developing countries, but adolescent mental health issues are relatively understudied in these area. This study is notable because it is among the first conducted in the developing world to explore adolescent mental health, and its relationship to parental domestic violence. The study was published online in February, and will be published in the April 2006 printed edition of the American Journal of Public Health.

Last year, the MHS Children Who Witness Violence program served more than 1,200 children of Cuyahoga County, Ohio, who had witnessed domestic violence. Clinically significant symptoms of depression and anxiety are common among these children. As stated by Dr. Michelle Hindin, one of the study authors, "Mental health and domestic violence are increasing public health concerns. Interventions that prevent domestic violence may also help prevent the severity of depressive symptoms in adolescents."

Reference
Hindin, M.J., & Bultiano, S. (2006, February 28). Associations between witnessing parental domestic violence and experiencing depressive symptoms in Filipino adolescents. American Journal of Public Health. Read the study abstract.




January 2006

Newer antidepressant medicines may help because they promote nerve growth in key areas of the brain.

Journal of Neurochemistry

Selective serotonin reuptake inhibitors (SSRIs) comprise a class of medicines introduced in the 1980's to treat depression. Prozac, the brand name of fluoxetine, was the first SSRI approved for use in the U.S.A. Clinical trials of its effectiveness in the treatment of major depressive disorder were conducted in Cleveland at the Case Western Reserve University School of Medicine and University Hospitals of Cleveland. Many clients of MHS find SSRIs to be helpful in the management of depressive symptoms.

SSRIs were so named because of their action within the nervous system, and this action was presumed to be the basis for their therapeutic effect. Serotonin is an important neurotransmitter in areas of the brain that govern appetite, mood, motivation, and other complex experiences. Research in the 1980's had revealed that disturbances in these experiences were often associated with a deficit of serotonin in the brains of those affected. This led to studies of new drugs that were known to selectively prevent serotonin (and not other neurotransmitters) from being naturally reabsorbed by the nerve cells that had released it into the synapse (the space between nerve cells, or neurons). The idea was to maintain more serotonin in the synapse, which would increase the number of serotonin molecules that were available to bind to receptor sites on nearby neurons, and therefore to increase the activity of those neurons. Many SSRI medicines have since been approved for use, and careful studies have shown that they do help some depressed people who did not benefit from other types of antidepressant medicine. However, even when SSRI's worked, patients reported that it often took four to six weeks for them to become effective.

A recent study suggests that SSRIs are effective because they promote the growth of neurons in key areas of the brain. (It is not known if this growth of new cells is related to the inhibition of serotonin reuptake.) The study, conducted at John Hopkins University School of Medicine, found that rats who were given SSRIs for four weeks showed increased nerve density in the frontal, parietal, and limbic areas of the brain. The brains of rats given the desipramine, a non-SSRI antidepressant, did not show this increased density. Vassilis Koliatsos, M.D., an author of the study, offered this interpretation: "It appears that SSRI antidepressants rewire areas of the brain that are important for thinking and feeling ... " He added that their findings "may offer a better explanation of why antidepressants are effective, and why they take time to work." If the researchers' finding are replicated by others, we may have a better understanding of the neurochemical events related to mood disorders, and new ideas to guide the search for more effective interventions.

Reference
Zhou, L., Huang, K. Kecojevic, A. Welsh, A.M., & Koliatsos, V.E. (2006) Evidence that serotonin reuptake modulators increase the density of serotonin innervation in the forebrain. Journal of Neurochemistry, Volume 96, Issue 2, pp. 396-406. To read the author's abstract, click here.




24 October 2005

People with schizophrenia have extraordinarily accurate visual perception in a selection task that fools most others.

Visual illusion used in the study, from the BBC website.

Look closely at the gray and black disk in the very center of the figure. (It's surrounded by the white and black "doughnut".) Which of the eight disks on the periphery of the figure most closely matches the disk in the center?

Time's up! If you're like most of the 33 study participants without schizophrenia who volunteered for this study at University College London, you chose the disk at about the 10 o'clock position. If you have a schizophrenic disorder, you almost certainly chose the disk at the 6 o'clock position - the correct choice. Of the 15 volunteers who had a chronic schizophrenic disorder, 12 made more accurate visual judgements than the most accurate of the volunteers without schizophrenia!

Most people perceive the central disk to be of lower contrast than it actually is because it is surrounded by the high-contrast, black-and-white doughnut. This is an instance in which awareness of context leads to an inaccurate judgement. In most situations -- visual, auditory, or even social -- the use of context is vital to accurate perception. The volunteers who had schizophrenia apparently were not influenced by the visual context when they made their choice. The study authors see this process as similar to the process by which people with schizophenia commonly evaluate social situations: they don't take into account the context that most people find helpful in interpreting the event.

The principal author, Dr. Dakin, told the BBC News: "Our findings may shed some light on the brain mechanisms involved in schizophrenia. Normally, contextual processes in the brain help us to focus on what's relevant and stop our brains being overwhelmed with information. This process seems to be less effective in the schizophrenic brain, possibly due to insufficient inhibition -- that is, the process by which cells in the brain switch each other off." The study results are fascinating, but the usefulness of the author's metaphor is unproven. Visual perception is a very different task than social perception.

Reference
Dakin, S., Carlin, P., & Hemsley, D. (2005, October 24). Weak suppression of visual context in chronic schizophrenia. Current Biology, 15 (20), pp. R822-R824.





30 October 2005

Schizophrenia and bipolar disorder are significant risk factors for homelessness.

One in five persons who have a schizophrenic disorder are homeless, according to this study conducted in the San Diego, Other serious mental disorders were also found to be risk factors for homelessness. Among those with bipolar disorder, 17% were homeless. Among those with major depression, 9% were homeless.

For comparison, consider that the total number of people who are homeless at any time during the year in the greater Cleveland area was estimated in 2002 be 21,811. This total would represent about 4.8% of the population of Cleveland, or 1.6% of the total population of Cuyahoga County.

Reference
Folsom, D.P., Hawthorne, W., Lindarner, L., et al. (2005). Prevalence and risk factors for homelessness and utilization of mental health services among 10,340 patients with serious mental illness in a large public mental health system. American Journal of Psychiatry.





3 August 2005

Adolescents exposed to violence are more likely to develop PTSD, serious depression, and addictions.

A growing body of research is discerning a reliable link between the childhood or adolescent experience of violence and the subsequent development of mental health problems. Researchers in this study conducted telephone surveys with 4,023 adolescents, ages 12-17 years. Parents gave permission for the interviews, and researchers took steps to ensure that adolescents had privacy and responded honestly. Among girls, 6.3% reported symptoms that would meet diagnostic criteria for posttraumatic stress disorder (PTSD) during the preceding six months. For boys, the prevalence of PTSD symtoms was 3.7%. Experiences and behaviors meeting criteria for a major depressive episode during the preceding six months were reported by 13.9% of girls, and 7.4% of boys. Symptoms meeting criteria for a substance-use disorder during the past year were reported by 6.2% of girls, and 8.2% of boys. About 19 percent of girls, and 16% of boys, met criteria for at least one of the three disorders.

Adolescents who reported being the victim of, or witnessing, sexual assault, physical assault, or other interpersonal violence were more likely to meet criteria for PTSD, major depression, or a substance-use disorder. This increased risk occurred even after demographic characteristics and substance-use problems among other family members had been taken into account. Older adolescents were more likely to meet criteria for the three diagnoses studied.

The study highlights the need to develop effective approaches to reduce the potential impacts of violence on children. MHS is the leading provider of assessment and treatment services for children referred to the Cuyahoga County Children Who Witness Violence program. These children are referred by police officers who are at the scene of an incident of domestic or other violence. Leaders of Cuyahoga County established the program in 1999, in response to early research indicating that children are particularly vulnerable to the development of a broad range of mental health, academic, and social problems after the experience of violent events. In 2003, there were 7,470 domestic violence offenses in the City of Cleveland, an average of more than 20 per day. The rate of domestic violence offenses in Cleveland is about 16 per 1,000 residents, more than three times the estimated national rate of 5 per 1,000 residents.

Reference
Kilpatrick, D.G., Ruggiero, K.J., Acierno, R., Saunders, B.E., Resnick, H. S., & Best, C.L. (2005). Violence and risk of PTSD, major depression substance abuse/dependence, and comorbidity: Results from the National Survey of Adolescents. Journal of Consulting and Clinical Psychology, 71 (4).





12 July 2005

Eleven patients develop compulsive gambling after taking the drug Mirapex, prescribed for their Parkinson's disease.

Nine men and two women with Parkinson's disease developed compulsive gambling and other compulsive behaviors after taking Mirapex, a drug manufactured by Boehringer Ingelheim. One of the nine men was reported to have lost $100,000 while gambling. Other patients developed compulsive sexual conduct. They all had been taking Mirapex to treat Parkinson's disease, a degenerative disorder that causes loss of nerve cells in a region of the brain called the substantia nigra. The disease is thought to be related to this regions's loss of, or insensitivity to, the neurotransmitter dopamine. Mirapex (also known by its generic name of pramipexole) is believed to exert its therapeutic effect by changing the D3 class of dopamine receptors. (In contrast, schizophrenia is thought to be related to excessive stimulation of dopamine receptors.)

Within a month of stopping treatment with Mirapex, the compulsive behaviors also stopped in all eight of the patients who were available for follow-up. Some patients, however, resumed their treatement with the drug. One man noted that he could golf again, but he did admit that he relinquished to his wife all control of the family's financial accounts.

The Wall Street Journal report notes that the full study was to be published in Archives of Neurology this September, but was posted online on 11 July 2005.

Reference
Hensley, Scott. (2005, July 12). Parkinson's drug may trigger compulsions. The Wall Street Journal, pp. B1 and B4.



For other news and information about MHS, click on the links below.

News of 2007

Recent Events

Key Documents

News of 2006

Events of 2006

Program Directors

News of 2005

Events of 2005

Service Outcomes

News of 2004

Events of 2004

Service Statistics

News of 2003

Events of 2003

Client Characteristics

Understanding Suicide
An MHS Web Essay

Healthcare & Psychology
Recent Developments

MHS Service Notes
Our eMail Newsletter


MHS; 1744 Payne Avenue; Cleveland, Ohio 44114 USA

Click here to open a separate window to the secure website of the Network for Good, where you may make a donation, and even set up recurring donations.

Copyright ©
Mental Health Services for Homeless Persons, Inc. (MHS)
1744 Payne Avenue; Cleveland, Ohio 44114 U.S.A.
216-623-6555 - TTY/TDD: 216-623-6540


The URL of this page is
http://www.mhs-inc.org/hc2006.asp
It was most recently updated on 6 September 2006.
We welcome your comments.
Please write to Joel[at]mhs-inc.org


Explore!   Enter search terms in the text-box below, and click the Search button to find information within the MHS website, or throughout the web.